1Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease[ J]. Medicine (Baltimore) , 1992, 71 (3) :139-164.
2Brewer G J, Fink JK, Hedera P. Diagnosis and treatment of Wilson disease [ J ]. Semin Neurol, 1999, 19 (3) :261-270.
3Brewer GJ, Askari FK. Wilson disease: clinical management and therapy[J]. J Hepatnl, 2005, 42(Snppl 1 ):s13-21.
4Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson's disease:a cohort study[J]. Gut, 2007, 56(1):115-120.
5Young AB, Shoulson I, Penney JB, Starosta-Rubinstein S, Gomez F, Travers H, et al. Huntington's disease in Venezuela: neurologie features and functional decline [ J ]. Neurology, 1986, 36(3) :244.
6Brewer GJ, Dick RD, Yuzbasiyan-Gurkan V, Tankanow R, Young AB, Kluin KJ. Initial therapy of patients with Wilson's disease with tetrathiomolybdate[ J]. Arch Neurol, 1991,48(1 ):42-47.
7Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins R J, Brewer GJ. Treatment of Wilson's disease with zinc: X. Intestinal metallothinnein induction[J]. J Lab Clin Med, 1992, 120(3):380- 386.
8Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice[J]. Brain Dev, 2006, 28 (3) :141-146.
9Brewer GJ, Askari F, Lorincz MT, Carlson M, Scbilsky M, Kluin K J, et al. Treatment of Wilson Disease with ammonium tetrathiomolybdate IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease [ J ]. Arch Neurol, 2006, 63 (4) :521-527.
9Goto H, Okada T, Kaneko S. Current state of Wilson disease patients in central Japan[J].Intern Med, 2010, 49(9) :809- 815.
10Wang LC, Wang JD, Tsai CR,et al. Clinical features and therapeutic response in Taiwan Residents children with Wilson's disease: 12 years of experience in a single center[J]. Pediatr Neonatol, 2010, 51(2) : 124-129.
